NeoStem, Inc. (AMEX:NBS), a leading-edge healthcare company that seeks to capitalize on existing stem cell therapy applications, has announced that the company’s CEO Robin Smith, MD, will ring the opening bell at the American Stock Exchange on October 23rd, 2007.
Dr. Smith commented, “On behalf of all the employees and stockholders of NeoStem I am very gratified to take part in one of our financial community’s longest-standing traditions. NeoStem’s recent listing on the American Stock Exchange was an important milestone for us and we are excited to join the ranks of so many successful companies. We look forward to broadening our exposure within this great community of investors and to continue our work to build shareholder value as part of Amex.”
Let us hear your thoughts:
